Protein analysis Protoarray
Tuesday, 16 September, 2008
Invitrogen Corporation has launched the ProtoArray Human Protein Microarray v4.1 which enables customers to screen biological samples or labeled probe of interest against approximately 8,200 unique human proteins in as little as one day. This technology has a broad range of applications - identification of novel protein biomarkers specific for infectious diseases, cancers, and autoimmune diseases; mapping protein-protein interactions important to biochemical pathways; identification of kinase/ ubiquitin ligase substrates for target discovery and validation; antibody specificity profiling for research and therapeutic antibody development; and small molecule-protein radioligand profiling for drug candidate selection and development Invitrogen Tel: 1800 331 627 www.invitrogen.com/protoarray.
The last mile of life sciences innovation
How do we translate technological possibility into meaningful real-world impact?
Machine learning uncovers patterns in DNA methylation
A new machine-learning method identifies differentially methylated DNA regions without sample...
HRT linked to lower dementia risk in some women
Hormone replacement therapy may reduce the risk of dementia — particularly for certain...
